Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea

NCT00327626 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped study was never started due to regional geopolitical conflict

Conditions

Interventions

Sponsor

Ionis Pharmaceuticals, Inc.